# Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

> **NCT04169763** · PHASE1 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 25 (estimated)

## Conditions studied

- Stage II Vulvar Cancer AJCC v8
- Stage III Vulvar Cancer AJCC v8
- Stage IIIA Vulvar Cancer AJCC v8
- Stage IIIB Vulvar Cancer AJCC v8
- Stage IIIC Vulvar Cancer AJCC v8
- Stage IVA Vulvar Cancer AJCC v8

## Interventions

- **DRUG:** Cisplatin
- **RADIATION:** External Beam Radiation Therapy
- **DRUG:** Nelfinavir

## Key facts

- **NCT ID:** NCT04169763
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-08-07
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04169763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04169763, "Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04169763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*